AU759409B2 - Preventives and/or remedies for obesity - Google Patents

Preventives and/or remedies for obesity Download PDF

Info

Publication number
AU759409B2
AU759409B2 AU56532/99A AU5653299A AU759409B2 AU 759409 B2 AU759409 B2 AU 759409B2 AU 56532/99 A AU56532/99 A AU 56532/99A AU 5653299 A AU5653299 A AU 5653299A AU 759409 B2 AU759409 B2 AU 759409B2
Authority
AU
Australia
Prior art keywords
stanniocalcin
obesity
cells
ser
leu
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU56532/99A
Other languages
English (en)
Other versions
AU5653299A (en
Inventor
Masaaki Goto
Masahiko Kinosaki
Nobuaki Nakagawa
Akihiro Tomoyasu
Kyoji Yamaguchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Pharmaceutical Co Ltd
Original Assignee
Daiichi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Pharmaceutical Co Ltd filed Critical Daiichi Pharmaceutical Co Ltd
Publication of AU5653299A publication Critical patent/AU5653299A/en
Assigned to DAIICHI PHARMACEUTICAL CO., LTD. reassignment DAIICHI PHARMACEUTICAL CO., LTD. Alteration of Name(s) of Applicant(s) under S113 Assignors: SNOW BRAND MILK PRODUCTS CO., LTD.
Application granted granted Critical
Publication of AU759409B2 publication Critical patent/AU759409B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Organic Chemistry (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Seal Device For Vehicle (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Lubricants (AREA)
  • Production Of Liquid Hydrocarbon Mixture For Refining Petroleum (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
AU56532/99A 1998-09-17 1999-09-17 Preventives and/or remedies for obesity Ceased AU759409B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP26300498 1998-09-17
JP10-263004 1998-09-17
PCT/JP1999/005080 WO2000016795A1 (fr) 1998-09-17 1999-09-17 Agents pour la prevention et/ou le traitement de l'obesite

Publications (2)

Publication Number Publication Date
AU5653299A AU5653299A (en) 2000-04-10
AU759409B2 true AU759409B2 (en) 2003-04-17

Family

ID=17383564

Family Applications (1)

Application Number Title Priority Date Filing Date
AU56532/99A Ceased AU759409B2 (en) 1998-09-17 1999-09-17 Preventives and/or remedies for obesity

Country Status (7)

Country Link
US (1) US6815417B1 (fr)
EP (1) EP1121936B1 (fr)
AT (1) ATE311197T1 (fr)
AU (1) AU759409B2 (fr)
CA (1) CA2342834A1 (fr)
DE (1) DE69928685T2 (fr)
WO (1) WO2000016795A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6902890B1 (en) 1999-11-04 2005-06-07 Diadexus, Inc. Method of diagnosing monitoring, staging, imaging and treating cancer
US8569240B2 (en) 2008-01-25 2013-10-29 Regeron, Inc. Methods of preventing or treating brain diseases
CN101969982A (zh) * 2008-01-25 2011-02-09 雷杰龙公司 脑疾病的预防或治疗用组合物
EP2730288B1 (fr) * 2011-07-09 2017-09-06 Tohoku University Stanniocalcine 1 pour la prévention ou le traitement de la fibrose pulmonaire

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995024411A1 (fr) * 1994-03-08 1995-09-14 Human Genome Sciences, Inc. Proteines des corpuscules de stannius, la stanniocalcine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988003949A1 (fr) * 1986-11-21 1988-06-02 Howard Florey Institute Of Experimental Physiology Proteine cs des corpuscules de stannius

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995024411A1 (fr) * 1994-03-08 1995-09-14 Human Genome Sciences, Inc. Proteines des corpuscules de stannius, la stanniocalcine

Also Published As

Publication number Publication date
DE69928685D1 (de) 2006-01-05
US6815417B1 (en) 2004-11-09
CA2342834A1 (fr) 2000-03-30
EP1121936A1 (fr) 2001-08-08
AU5653299A (en) 2000-04-10
EP1121936B1 (fr) 2005-11-30
ATE311197T1 (de) 2005-12-15
EP1121936A4 (fr) 2004-11-17
WO2000016795A1 (fr) 2000-03-30
DE69928685T2 (de) 2006-08-24

Similar Documents

Publication Publication Date Title
AP815A (en) An obesity (ob) polypeptide capable of modulating body weight, nucleic acids therefore, and diagnostic and therapeutic use thereof.
Karaplis et al. PTH and PTHrP effects on the skeleton
CN101522707B (zh) 肌肉生长抑制素拮抗剂
JP5607176B2 (ja) 新規ペプチドおよびその用途
WO1994001557A1 (fr) Proteine induisant l'osteogenese
JP2001512319A (ja) 細胞のＮＦ−κＢ活性化を調節するための組成物および方法
CN101300269A (zh) 机械生长因子肽及其用途
KR101744763B1 (ko) Bmp 유래 펩타이드 및 이의 용도
EP1967210A1 (fr) Nouvelle application de l'apéline
AU759409B2 (en) Preventives and/or remedies for obesity
JPH08510207A (ja) ウロキナーゼプラスミノーゲンアクチベーターフラグメント
US6743895B1 (en) Bone stimulating factor
Umekawa et al. Osteopontin mRNA in the kidney on an experimental rat model of renal stone formation without renal failure
KR101637497B1 (ko) 골형성 펩타이드 및 이의 용도
HUT72068A (en) Synthetic peptide derivatives and the salts thereof
MXPA00001427A (es) Secuencias de nucleotidos frazzled, productos de expresion, composiciones y usos.
CN1142178C (zh) 新肽和以其为有效成分的骨病治疗剂
AU783373B2 (en) Epithelial cell growth inhibitors
US20220133837A1 (en) Peptide inhibitors of nf kappa b and use thereof in treatment of covid-19 and inflammatory diseases
US20240180997A1 (en) Peptide inhibitors of nf kappa b and use thereof in treatment of covid-19 and inflammatory diseases
JP2001335596A (ja) 新規ペプチド及びその医薬用途
Lecanda et al. Impaired intramembranous bone formation in connexin43 null mice
DE60309850T2 (de) Cg8327 und srm in der regulation von energiehomeostase
WO2002072134A1 (fr) Remedes pour l'arthrite deformante et pour l'arthrite rhumatoide
JP2000229880A (ja) 骨形成促進剤

Legal Events

Date Code Title Description
PC1 Assignment before grant (sect. 113)

Owner name: DAIICHI PHARMACEUTICAL CO., LTD

Free format text: THE FORMER OWNER WAS: SNOW BRAND MILK PRODUCTS CO., LTD.

FGA Letters patent sealed or granted (standard patent)